Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Effects of photobiomodulation on annulus fibrosus cells derived from degenerative disc disease patients exposed to microvascular endothelial cells conditioned medium

Our results show that PBM selectively inhibited the EC-mediated production of inflammatory mediators, catabolic enzymes, and neurotrophins by human AF cells in a dose- and wavelength-dependent manner.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors examined photobiomodulation at wavelengths of 645, 525 and 465 nm and doses of 16, 32 and 64 J/cm2 on human annulus fibrosus cells exposed to endothelial cell conditioned medium, in cell culture. They report that the light selectively reduced production of inflammatory mediators, catabolic enzymes and neurotrophins in a dose- and wavelength-dependent manner. The abstract does not report patient outcomes, and the authors suggest the approach could be a treatment strategy for disc degeneration.

Who or what was studied
Human annulus fibrosus cells derived from degenerative disc disease patients, exposed to microvascular endothelial cell conditioned medium (cell culture study)
Wavelengths
645, 525, 465 nm
Limits stated in the abstract
The abstract describes an in vitro cell study and reports no clinical outcomes in patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Intervertebral disc (IVD) degeneration with chronic low back pain is associated with neo-vascularisation into the deeper IVD regions. During this process, endothelial cells (ECs), which are primarily responsible for angiogenesis, interact with the adjacent annulus fibrosus (AF) cells, which are the first line of defence against the invasion of vascular structures into deeper IVD regions. However, the accumulation of inflammatory and catabolic enzymes that results from this interaction promotes matrix degradation and an inflammatory response. Thus, regulating the production of these mediators and catabolic enzymes could ameliorate IVD degeneration. Photobiomodulation (PBM) therapy is a non-invasive stimulation known to have biologically beneficial effects on wound healing, tissue repair, and inflammation. Here, we examined the effects of PBM, administered at various wavelengths (645, 525, and 465 nm) and doses (16, 32, and 64 J/cm2), on EC-stimulated human AF cells. Our results show that PBM selectively inhibited the EC-mediated production of inflammatory mediators, catabolic enzymes, and neurotrophins by human AF cells in a dose- and wavelength-dependent manner. These results suggest that PBM could be a superior and advanced treatment strategy for IVD degeneration.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
465 nm
Energy density (fluence)
64 J/cm2

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Wound healing, Angiogenesis, Inflammation, Wavelength, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies